Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. From Wikipedia
The collaboration aims to co-develop Zealand's petrelintide and combine it with Roche's CT-388 to address the growing weight-loss drug market.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FZ2YZCJLPZN2NLQBJ5CO4ZHFIA.jpg)